| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2601300 | Toxicology Letters | 2008 | 6 Pages |
Abstract
The distinction between carcinogens with DNA-reactive and epigenetic modes of action and the application of mode-of-action considerations to risk assessment is reviewed. A bioindicator-based risk assessment strategy is described. This approach involves the use of mechanistic data to establish a “toxicologically insignificant daily intake”.
Keywords
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Gary M. Williams,